TP53 Mutation Triggers CD8+ T Cell Exhaustion Causing Therapy-Resistant Urothelial Cancer
In a groundbreaking study published in the British Journal of Cancer, researchers have illuminated the complex and detrimental impact of TP53 mutations on the immune landscape of urothelial carcinoma (UC). The...
Read moreDetails






















